標的型投与のための内生反応性酸素種によって活性化された有機一酸化炭素前薬
Inga Cernauskiene1, Claudio D Navo2, Carlos Labão-Almeida3
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
Journal of the American Chemical Society
|July 4, 2025
まとめ
新しい金属のない一酸化炭素 (CO) プロドラッグは,活性酸素種 (ROS) 豊富な疾患の治療に標的を絞った投与を可能にします. 金属ベースの治療法より安全で 治療の可能性を高めます
科学分野:
- 生物結合化学
- 薬剤化学
- 薬物投与システム
背景:
- 一酸化炭素 (CO) は,炎症や癌などの高レベルの反応性酸素種 (ROS) を特徴とする状態で治療的可能性を示しています.
- 標的型CO投与における現在の制限は,その臨床的応用を妨げ,高度なCO前薬の開発を必要とする.
- 金属関連毒性は,既存の金属ベースの治療戦略を懸念しています.
研究 の 目的:
- 新しい金属のない活性化炭素 (CO) プロドラッグを開発する.
- ターゲットを絞った CO 排出と関連した課題を克服し,金属関連の毒性を軽減する.
- 治療効果を高めるため,抗体のようなバイオ分子にCO前薬の局所的結合を可能にします.
主な方法:
- アルデヒドベースのCO前薬の設計と合成
- 生理学的条件下での前薬の安定性の評価
- COの放出を誘発する活性化メカニズム
- 固体フェーズペプチド合成による合成ペプチドにCO-プロドラッグの構成要素を組み込む.
- 前薬と治療用抗体 (トラストズマブ) のサイト固有の生物結合.
主要な成果:
- 開発されたCO前薬は生理学的条件下では安定し,CO,2-エチル-1-ブーテンとチオールキャリアを激素活性化時に放出する.
- 前薬とトラストズマブとの結合は成功し,前薬と抗体の比率は23であった.
- HER2を多く発現する細胞では,効率的で腫瘍特異的なCO放出が示された.
- 金属のないアプローチは,金属に関連した毒性を回避します.
結論:
- 新しい,金属のない,急性活性化CO前薬戦略が成功裏に開発されました.
- この前薬はペプチドおよび抗体療法に効果的に組み込まれ,標的投与が可能である.
- この発見は,ROSが豊富な環境におけるCOの治療的応用を探求するための新しい道を開きます.
- このアプローチは,様々なペプチドおよびタンパク質ベースの治療法に広く適用できます.
関連する概念動画
Radical Autoxidation
2.3K
The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.3K
Oxidation and Reduction of Organic Molecules
7.7K
Energy production within a cell involves many coordinated chemical pathways. Most of these pathways are combinations of oxidation and reduction reactions, which occur at the same time. An oxidation reaction strips an electron from an atom in a compound, and the addition of this electron to another compound is a reduction reaction. Because oxidation and reduction usually occur together, these pairs of reactions are called redox reactions.
The removal of an electron from a molecule, results in a...
The removal of an electron from a molecule, results in a...
7.7K
Phase I Oxidative Reactions: Overview
383
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
383
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids
6.1K
Diols are compounds with two hydroxyl groups. In addition to syn dihydroxylation, diols can also be synthesized through the process of anti dihydroxylation. The process involves treating an alkene with a peroxycarboxylic acid to form an epoxide. Epoxides are highly strained three-membered rings with oxygen and two carbons occupying the corners of an equilateral triangle. This step is followed by ring-opening of the epoxide in the presence of an aqueous acid to give a trans diol.
6.1K
Oxidation of Phenols to Quinones
3.5K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.5K
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems
160
Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
160


